Abemaciclib

  • 1 lab in 1 country
  • Funder: KWF Kankerbestrijding
  • Animals2

Outcomes

2

Physical function

upin mice1

1 study
  1. Abemaciclib improves physical function in mice.

    “In aged mice, abemaciclib and agn194310 reduced systemic NASP expression and improved physical performance.”

    Animals

    Disruption of CDK4/6-RARα-NF-κB axis attenuates senescence-associated inflammation and improves function during aging and following chemotherapy

    Nature aging17 Jul 2026

NF-κB-associated SASP

downin mouse cells1

1 study
  1. Abemaciclib decreases NF-κB-associated SASP in mouse cells.

    “short-term inhibition of CDK4/6 with abemaciclib suppresses established NASP in pre-existing senescent cells both in vitro and in vivo.”

    Cellspre-existing senescencesenescent cellsshort-term

    Disruption of CDK4/6-RARα-NF-κB axis attenuates senescence-associated inflammation and improves function during aging and following chemotherapy

    Nature aging17 Jul 2026

More on NF-κB-associated SASP

Latest

Nov 2025: 1Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 2Aug 2026: 0Sep 2026: 0Oct 2026: 03 in 12 months